Works by Reeder, Craig

Results: 39
    1
    2

    Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00794-x
    By:
    • Fonseca, Rodrigo;
    • Arribas, Mariano;
    • Wiedmeier-Nutor, Julia E.;
    • Kusne, Yael N.;
    • González Vélez, Miguel;
    • Kosiorek, Heidi E.;
    • Butterfield, Richard J.;
    • Kirsch, Ilan R.;
    • Mikhael, Joseph R.;
    • Stewart, A. Keith;
    • Reeder, Craig;
    • Larsen, Jeremy;
    • Bergsagel, P. Leif;
    • Fonseca, Rafael
    Publication type:
    Article
    3

    Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00794-x
    By:
    • Fonseca, Rodrigo;
    • Arribas, Mariano;
    • Wiedmeier-Nutor, Julia E.;
    • Kusne, Yael N.;
    • González Vélez, Miguel;
    • Kosiorek, Heidi E.;
    • Butterfield, Richard J.;
    • Kirsch, Ilan R.;
    • Mikhael, Joseph R.;
    • Stewart, A. Keith;
    • Reeder, Craig;
    • Larsen, Jeremy;
    • Bergsagel, P. Leif;
    • Fonseca, Rafael
    Publication type:
    Article
    4

    "Direct to Drug" screening as a precision medicine tool in multiple myeloma.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 5, p. 1, doi. 10.1038/s41408-020-0320-7
    By:
    • Bonolo de Campos, Cecilia;
    • Meurice, Nathalie;
    • Petit, Joachim L.;
    • Polito, Alysia N.;
    • Zhu, Yuan Xiao;
    • Wang, Panwen;
    • Bruins, Laura A.;
    • Wang, Xuewei;
    • Lopez Armenta, Ilsel D.;
    • Darvish, Susie A.;
    • Ahmann, Greg J.;
    • Henderson, Kimberly J.;
    • Tian, Shulan;
    • Kruse, Jonas J.;
    • Stewart, William M.;
    • Larsen, Jeremy T.;
    • Reeder, Craig B.;
    • Dingli, David;
    • Kapoor, Prashant;
    • Kumar, Shaji K.
    Publication type:
    Article
    5
    6

    Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 2, p. 308, doi. 10.1080/10428194.2020.1832669
    By:
    • Gunaratne, Madugodaralalage D. S. K.;
    • Sahakian, Alexander J.;
    • Abeykoon, Jithma P.;
    • Ansell, Stephen M.;
    • Gertz, Morie A.;
    • Kapoor, Prashant;
    • Paulus, Aneel;
    • Ailawadhi, Sikander;
    • Reeder, Craig B.;
    • Witzig, Thomas E.;
    • Habermann, Thomas M.;
    • Novak, Anne J.;
    • Lacy, Martha Q.;
    • Kyle, Robert A.;
    • Go, Ronald S.;
    • Paludo, Jonas
    Publication type:
    Article
    7

    A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 9, p. 2128, doi. 10.1080/10428194.2017.1416368
    By:
    • Sonbol, Mohamad Bassam;
    • Hilal, Talal;
    • Rosenthal, Allison C.;
    • Leis, Jose F.;
    • Northfelt, Donald W.;
    • Bergsagel, Peter Leif;
    • Reeder, Craig B.;
    • Dueck, Amylou C.;
    • Kosiorek, Heidi E.;
    • Ginos, Brenda F.;
    • Conley, Christopher R.;
    • Gano, Katherine M.;
    • Nichols, Craig S.;
    • Johnston, Patrick B.;
    • Habermann, Thomas M.;
    • Inwards, David J.;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.
    Publication type:
    Article
    8

    Ibrutinib-induced acute liver failure.

    Published in:
    2018
    By:
    • Kahn, Allon;
    • Horsley-Silva, Jennifer L.;
    • Lam-Himlin, Dora M.;
    • Reeder, Craig B.;
    • Douglas, David D.;
    • Carey, Elizabeth J.
    Publication type:
    Letter to the Editor
    9

    Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
    By:
    • Chohan, Karan L.;
    • Paludo, Jonas;
    • Vallumsetla, Nishanth;
    • Larson, Dirk;
    • King, Rebecca L.;
    • He, Rong;
    • Gonsalves, Wilson;
    • Inwards, David;
    • Witzig, Thomas E.;
    • Swaika, Abhisek;
    • Jain, Tania;
    • Leung, Nelson;
    • Ailawadhi, Sikander;
    • Reeder, Craig B.;
    • Lacy, Martha Q.;
    • Rajkumar, S. Vincent;
    • Kumar, Shaji;
    • Kyle, Robert A.;
    • Gertz, Morie A.;
    • Ansell, Stephen M.
    Publication type:
    Article
    10
    11

    <italic>MYD88</italic> mutation status does not impact overall survival in Waldenström macroglobulinemia.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 2, p. 187, doi. 10.1002/ajh.24955
    By:
    • Abeykoon, Jithma P.;
    • Paludo, Jonas;
    • King, Rebecca L.;
    • Ansell, Stephen M.;
    • Gertz, Morie A.;
    • LaPlant, Betsy R.;
    • Halvorson, Alese E.;
    • Gonsalves, Wilson I.;
    • Dingli, David;
    • Fang, Hong;
    • Rajkumar, S. Vincent;
    • Lacy, Martha Q.;
    • He, Rong;
    • Kourelis, Taxiarchis;
    • Reeder, Craig B.;
    • Novak, Anne J.;
    • McPhail, Ellen D.;
    • Viswanatha, David S.;
    • Witzig, Thomas E.;
    • Go, Ronald S.
    Publication type:
    Article
    12

    Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 8, p. 759, doi. 10.1002/ajh.24762
    By:
    • Larsen, Jeremy T.;
    • Shanafelt, Tait D.;
    • Leis, Jose F.;
    • LaPlant, Betsy;
    • Call, Tim;
    • Pettinger, Adam;
    • Hanson, Curtis;
    • Erlichman, Charles;
    • Habermann, Thomas Matthew;
    • Reeder, Craig;
    • Nikcevich, Daniel;
    • Bowen, Deborah;
    • Conte, Michael;
    • Boysen, Justin;
    • Secreto, Charla;
    • Lesnick, Connie;
    • Tschumper, Renee;
    • Jelinek, Diane;
    • Kay, Neil E.;
    • Ding, Wei
    Publication type:
    Article
    13

    Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 5, p. 448, doi. 10.1002/ajh.24671
    By:
    • Bennani, N. Nora;
    • LaPlant, Betsy R.;
    • Ansell, Stephen M.;
    • Habermann, Thomas. M.;
    • Inwards, David J.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Porrata, Luis F.;
    • Colgan, Joseph P.;
    • Markovic, Svetomir N.;
    • Nowakowski, Grzegorz S.;
    • Macon, William R.;
    • Reeder, Craig B.;
    • Mikhael, Joseph R.;
    • Northfelt, Donald W.;
    • Ghobrial, Irene M.;
    • Witzig, Thomas E.
    Publication type:
    Article
    14
    15

    Lenalidomide, cyclophosphamide and dexamethasone (CRd) for newly diagnosed multiple myeloma: Results from a phase 2 trial.

    Published in:
    American Journal of Hematology, 2011, v. 86, n. 8, p. 640, doi. 10.1002/ajh.22053
    By:
    • Kumar, Shaji K.;
    • Lacy, Martha Q.;
    • Hayman, Suzanne R.;
    • Stewart, Keith;
    • Buadi, Francis K.;
    • Allred, Jacob;
    • Laumann, Kristina;
    • Greipp, Philip R.;
    • Lust, John A.;
    • Gertz, Morie A.;
    • Zeldenrust, Steven R.;
    • Bergsagel, P. Leif;
    • Reeder, Craig B.;
    • Witzig, Thomas E.;
    • Fonseca, Rafael;
    • Russell, Stephen J.;
    • Mikhael, Joseph R.;
    • Dingli, David;
    • Rajkumar, S. Vincent;
    • Dispenzieri, Angela
    Publication type:
    Article
    16
    17

    Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 6, p. 456, doi. 10.1016/j.clml.2023.03.002
    By:
    • Wiedmeier-Nutor, Julia E.;
    • Iqbal, Madiha;
    • Rosenthal, Allison C.;
    • Bezerra, Evandro D.;
    • Garcia-Robledo, Juan Esteban;
    • Bansal, Radhika;
    • Johnston, Patrick B.;
    • Hathcock, Matthew;
    • Larsen, Jeremy T.;
    • Leif Bergsagel, P.;
    • Wang, Yucai;
    • Reeder, Craig B.;
    • Leis, Jose F.;
    • Fonseca, Rafael;
    • Palmer, Jeanne M.;
    • Gysbers, Brianna J.;
    • Mwangi, Raphael;
    • Warsame, Rahma M.;
    • Kourelis, Taxiarchis;
    • Hayman, Suzanne R.
    Publication type:
    Article
    18

    Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell Lymphoma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 2, p. e89, doi. 10.1016/j.clml.2021.08.011
    By:
    • Iqbal, Madiha;
    • Castano, Yennifer Gil;
    • Paludo, Jonas;
    • Rosenthal, Allison;
    • Zhuo Li;
    • Beltran, Manuel;
    • Moustafa, Muhamad Alhaj;
    • Inwards, David;
    • Porrata, Luis;
    • Micallef, Ivana;
    • Bisneto, Jose C. Villasboas;
    • Johnston, Patrick;
    • Ansell, Stephen M.;
    • Reeder, Craig;
    • Murthy, Hemant;
    • Roy, Vivek;
    • Foran, James;
    • Tun, Han W.;
    • Kharfan-Dabaja, Mohamed A.;
    • Ayala, Ernesto
    Publication type:
    Article
    19

    Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 355, doi. 10.1016/j.clml.2021.01.002
    By:
    • Parrondo, Ricardo D.;
    • Moustafa, Muhamad Alhaj;
    • Reeder, Craig;
    • Sher, Taimur;
    • Roy, Vivek;
    • Muchtar, Eli;
    • Warsame, Rahma;
    • Alegria, Victoria;
    • Gonsalves, Wilson;
    • Dingli, David;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Chanan-Khan, Asher A.;
    • Ailawadhi, Sikander
    Publication type:
    Article
    20

    A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma.

    Published in:
    2018
    By:
    • Padrnos, Leslie;
    • Ernst, Brenda;
    • Dueck, Amylou C.;
    • Kosiorek, Heidi E.;
    • Ginos, Brenda F.;
    • Toro, Angela;
    • Johnston, Patrick B.;
    • Habermann, Thomas M.;
    • Leis, Jose F.;
    • Mikhael, Joseph R.;
    • Nowakowski, Grzegorz S.;
    • Colgan, Joseph;
    • Porrata, Luis;
    • Ansell, Stephen M.;
    • Witzig, Thomas E.;
    • Reeder, Craig
    Publication type:
    journal article
    21
    22
    23

    Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia.

    Published in:
    2018
    By:
    • Paludo, Jonas;
    • Abeykoon, Jithma P.;
    • Shreders, Amanda;
    • Ansell, Stephen M.;
    • Kumar, Shaji;
    • Ailawadhi, Sikander;
    • King, Rebecca L.;
    • Koehler, Amber B.;
    • Reeder, Craig B.;
    • Buadi, Francis K.;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Dingli, David;
    • Witzig, Thomas E.;
    • Go, Ronald S.;
    • Gonsalves, Wilson I.;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Leung, Nelson;
    • Habermann, Thomas M.
    Publication type:
    journal article
    24
    25

    Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia.

    Published in:
    British Journal of Haematology, 2017, v. 179, n. 1, p. 98, doi. 10.1111/bjh.14826
    By:
    • Paludo, Jonas;
    • Abeykoon, Jithma P.;
    • Kumar, Shaji;
    • Shreders, Amanda;
    • Ailawadhi, Sikander;
    • Gertz, Morie A.;
    • Kourelis, Taxiarchis;
    • King, Rebecca L.;
    • Reeder, Craig B.;
    • Leung, Nelson;
    • Kyle, Robert A.;
    • Buadi, Francis K.;
    • Habermann, Thomas M.;
    • Dingli, David;
    • Witzig, Thomas E.;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Go, Ronald S.;
    • Lin, Yi;
    • Gonsalves, Wilson I.
    Publication type:
    Article
    26
    27
    28
    29

    AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenström macroglobulinaemia.

    Published in:
    British Journal of Haematology, 2014, v. 164, n. 3, p. 352, doi. 10.1111/bjh.12633
    By:
    • Paulus, Aneel;
    • Chitta, Kasyapa;
    • Akhtar, Sharoon;
    • Personett, David;
    • Miller, Kena C.;
    • Thompson, Kevin J.;
    • Carr, Jennifer;
    • Kumar, Shaji;
    • Roy, Vivek;
    • Ansell, Stephen M.;
    • Mikhael, Joseph R.;
    • Dispenzieri, Angela;
    • Reeder, Craig B.;
    • Rivera, Candido E.;
    • Foran, James;
    • Chanan‐Khan, Asher
    Publication type:
    Article
    30
    31
    32

    A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma.

    Published in:
    British Journal of Haematology, 2012, v. 156, n. 3, p. 326, doi. 10.1111/j.1365-2141.2011.08949.x
    By:
    • Khan, Meaghan L.;
    • Reeder, Craig B.;
    • Kumar, Shaji K.;
    • Lacy, Marthy Q.;
    • Reece, Donna E.;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Greipp, Phillip;
    • Hayman, Suzanne;
    • Zeldenhurst, Steven;
    • Dingli, David;
    • Lust, John;
    • Russell, Stephen;
    • Laumann, Kristina M.;
    • Mikhael, Joseph R.;
    • Leif Bergsagel, P.;
    • Fonseca, Rafael;
    • Vincent Rajkumar, S.;
    • Keith Stewart, A.
    Publication type:
    Article
    33
    34

    Histologic remission of cardiac amyloidosis: a case report.

    Published in:
    Amyloid, 2012, v. 19, n. 2, p. 106, doi. 10.3109/13506129.2012.660892
    By:
    • Nelson, Matthew R.;
    • Lanza, Louis A.;
    • Reeder, Craig B.;
    • Scott, Robert L.;
    • McCullough, Ann E.;
    • Chandrasekaran, Krishnaswamy;
    • Click, Roger L.
    Publication type:
    Article
    35
    36
    37
    38
    39